ODDP 2019

Oncology Drug Development in Practice (ODDP) 2019 is a 3-day educational program designed for professionals in industry and academia who wish to acquire or expand their knowledge of drug development in oncology.

Target audiences

This program is of particular interest to drug development professionals in pharma and biotech companies. It is also relevant for (junior) physicians at academic or private clinical centers involved in the clinical development of new cancer therapies. They will benefit from participating in parts A and B combined or part B only, depending on their starting oncology knowledge.

Part A provides basic education on cancer biology, diagnosis and treatment and is therefore of interest to anyone looking to acquire general oncology knowledge.

Parts A (day 1) and B (days 2 and 3) may be booked separately or combined. For successful participation in either part, an understanding of the basic principles of biology and medicine at the graduate level is recommended.

Why participate in ODDP 2019?

Exclusively focused on oncology
Impressive 15-year track record
High experienced faculty from academia and industry
High participant satisfaction over the years
Particularly useful for those entering oncology drug development
No upfront oncology knowledge required for successful participation
Covers the complete cancer drug development process
Provides stand-alone introduction into oncology for a broad audience

FOR ATTENDEES ONLY

Course App

All course materials will be provided to the attendees via the special course app, which contains the final program, faculty presentations, background materials and the participants list.

COURSE APP